henhaobio
Sign in

bioRxivGenomicsPreprint

A repurposed, blood gene signature is associated with poor outcomes in SARS-CoV-2

Brenda M. Juan-Guardela, Jiehuan SuniD, Tong ZhangiD, Bing XuiD, Gaetane C. MichaudiD, Jose D. Herazo‐MayaiD

PDFDOI

Abstract

Poor outcomes after SARS-CoV-2 infection are difficult to predict. Survivors may develop pulmonary fibrosis. We previously identified a 52-gene signature in peripheral blood, predictive of mortality in Idiopathic Pulmonary Fibrosis. In this study, we analyzed this signature in SARS-CoV-2 infected individuals and identified genomic risk profiles with significant differences in outcomes. Analysis of single cell expression data shows that monocytes, red blood cells, neutrophils and dendritic cells are the cellular source of the high risk gene signature.

Citations
0

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISTourki '23Budhraja '22Cillo '21Pekayvaz '21Yoon '23Yang '22
77% semantic matchGenomics
Bochra Tourki, Minxue Jia, Τheodoros Karampitsakos+17 more·bioRxiv·Oct 22, 2023· 1 citations